Across its top 1 institutional holders, 1D5A's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 9/100, avg. turnover score 17/100).
Quarterly Activity
Recent Activity
+$0.0
Total Buy Value
$0.0
Total Sell Value
New buy0
Trim0
Add0
Sold out0
0
Net Buyers
0
Net Sellers
Smart Money Convergence
1D5A does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.
13F data as of 2026-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
No Form 144 planned sale filings in the last 90 days
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
No Form 8-K filings for this ticker
CUSIP
72942A107
FAQ
Who are the top institutional investors holding PLX PHARMA INC (1D5A)?
Major stakeholders currently include Financial Gravity Asset Management, Inc. ($0.0). Based on the latest 13F filings, there are a total of 1 tracked investment funds and institutions maintaining positions in 1D5A.
What is the overall institutional sentiment toward 1D5A recently?
Institutional sentiment appears Neutral. During the most recent reporting quarter, the stock experienced no significant net capital flow from tracked managers.
Which institutions have been selling or reducing their 1D5A positions?
In the latest period, no tracked funds trimmed or exited their positions in 1D5A.
Are there any notable investors adding 1D5A to their portfolios?
No tracked institutions opened new positions or added to their existing holdings in 1D5A during the last reporting period.
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter